Norstella
Norstella is a global life sciences intelligence company offering AI-powered data, analytics, and consulting solutions to pharmaceutical, biotech, and life sciences organizations across the drug development lifecycle — from pipeline to patient.
- Company typePrivate
- Founded2022
- HeadquartersYardley, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingSoftware
What Norstella does
Norstella is a global life sciences intelligence company that sells AI-powered data, analytics, and consulting solutions to pharmaceutical, biotech, medtech, and clinical research organizations. The company was formed through the November 2022 merger of Norstella and Citeline, valued at approximately $5 billion, and now operates six market-leading brands — Citeline (clinical trial intelligence and pipeline data), Evaluate (market forecasting and commercial intelligence), MMIT (real-world data on drug coverage and patient access), Panalgo (healthcare data analytics), Skipta (HCP digital engagement across 50+ specialty communities), and The Dedham Group (market access consulting). Its central platform, NorstellaLinQ, is described as the biopharma industry's first fully integrated data asset, combining 74+ billion linked data points spanning open and closed claims, lab results, structured EMR, and proprietary forecasting, clinical, regulatory, payer, and commercial intelligence.
The company monetizes primarily through annual enterprise subscriptions sold via direct field sales to pharma and biotech clients across the drug development lifecycle. Norstella AI — trained on cleansed, tokenized proprietary data — powers brand-specific AI features including Evaluate Ask Ella (conversational RAG over commercial intelligence), Panalgo Ella AI (plain-language cohort building), MMIT Searchlight (AI policy summarization), Norstella Atlas (sourced deliverable generation), and Citeline Protocol Smart Design (auto-generation of trial endpoints and inclusion/exclusion criteria). The company reports more than two dozen AI agents in production and is building an agentic platform with autonomous execution on a stated roadmap.
Norstella operates from 12+ offices across the US, UK, Netherlands, Japan, China, and India, including Global Capability Centers in Bangalore, Gurgaon, and Noida. Leadership includes Executive Chair Fred Hassan, CEO Michael Gallup, CFO Dan Tempesta, and CTO Andrew Augustine. Revenue is not publicly disclosed; based on 1,500–1,600+ headcount and an enterprise SaaS business model, revenue is most plausibly in the $500M–$1B band.
Norstella firmographics
Firmographics- Name
- Norstella
- Legal name
- Caerus US 1, Inc.
- Website
- https://norstella.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Norstella is a global life sciences intelligence company offering AI-powered data, analytics, and consulting solutions to pharmaceutical, biotech, and life sciences organizations across the drug development lifecycle — from pipeline to patient.
- Ownership category
- akta.pro rank
Norstella industry classification
Industry- Product category
- Pharmaceutical Intelligence / Life Sciences Analytics
- NAICS
- Software Publishers (5132), Other Scientific and Technical Consulting Services (54169)
- akta.pro primary industry
- Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)
- akta.pro secondary industry
- Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
Keywords
Where Norstella is headquartered
LocationHeadquarters
- HQ city
- Yardley
- HQ country
- United States
- HQ region
- North America
Offices12 records
Markets served
Norstella business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Pharma Intelligence SaaS Platforms: Subscription-based access to data and analytics platforms across multiple brands serving pharmaceutical, biotech, and life sciences companies throughout the drug development lifecycle
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription pricing varies by brand and scope |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels11 records
Norstella product offering
Product offeringCore offering
Norstella is a multi-brand pharmaceutical intelligence platform that provides AI-powered data, analytics, and clinical/commercial intelligence solutions across the entire drug development lifecycle — from pipeline to patient. Through its brands (Citeline, Evaluate, MMIT, Panalgo, Skipta, The Dedham Group), it offers subscription-based SaaS platforms integrating real-world data (74+ billion data points), clinical trial intelligence, market access data, forecasting, and patient journey analytics to pharmaceutical, biotech, and life sciences clients.
Product overview
Norstella is a multi-brand pharma intelligence platform company that provides a unified ecosystem of data, technology, and expertise across the drug development lifecycle — from pipeline to patient. The company is organized around six market-leading brands: Citeline (clinical trial intelligence, pipeline data, and regulatory/commercial publications), Evaluate (market forecasting and commercial intelligence), MMIT (real-world data on drug coverage, patient access, and payer landscapes), Panalgo (instant health data analytics platform), Skipta (HCP digital engagement across 50+ specialty communities), and The Dedham Group (market access strategy consulting). Central to the portfolio is NorstellaLinQ — a fully integrated data asset with 74 billion+ linked data points combining real-world data with proprietary intelligence across all brands. Norstella's own AI engine (Norstella AI) powers decision-making across all brands, with brand-specific AI features including Evaluate Ask Ella (AI analyst for commercial intelligence), MMIT Searchlight (AI-powered policy alerts), Panalgo Ella AI (conversational data querying), Norstella Atlas (AI-powered sourced deliverable generation), and Citeline SmartSolutions (AI-enabled protocol design).
Differentiator
Problem solved
Functional benefit
Brands
- Citeline: Clinical solutions and patient-focused business intelligence offerings for life sciences professionals
- Evaluate
- MMIT
- Panalgo
- Skipta
- The Dedham Group
- NorstellaLinQ
- Norstella AI
Products and services
- NorstellaLinQ The biopharma industry's first fully integrated data asset, combining 74 billion+ linked data points from real-world data (open/closed claims, lab results, EMR) with Norstella's proprietary forecasting, clinical, regulatory, payer, and commercial intelligence across all six Norstella brands.
- Norstella AI
Quantifiable outcome
- 30-60% improvements in enrollment for partnered clinical trial programs
- +2 more outcomes
Companies that use Norstella
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles3 records
Norstella technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature8 records
Norstella partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- RecursioncoreExpanded strategic partnership where Citeline's real-world data and evidence capabilities integrate with Recursion's AI-enabled ClinTech platform, enabling more precise trial design, improved site selection, and faster development decisions. Partnership has yielded 30-60% improvements in enrollment for partnered programs.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Norstella competitors and assessment
Company assessmentDirect peers
- IQVIA: IQVIA is the largest contract research organization and pharma intelligence provider, offering clinical trial services, real-world data, technology solutions, and analytics. It directly overlaps Norstella across clinical trial intelligence, real-world evidence, and commercial analytics for the same pharma/biotech customer base.
- Clarivate: Clarivate provides intellectual property, scientific, and academic research intelligence, including life sciences and pharma R&D analytics. It is a direct competitor to Norstella's pharma intelligence brands, particularly in research analytics, regulatory intelligence, and pipeline data, with overlapping leadership pedigree (Norstella CTO previously served as Clarivate CTO).
- Veeva Systems: Veeva is a leading life sciences cloud platform providing CRM, regulatory, clinical, and quality solutions to pharma and biotech. It directly competes with Norstella's Citeline and Evaluate offerings in clinical trial data, regulatory intelligence, and commercial intelligence, serving overlapping enterprise pharma customers.
Broad incumbents
- ICON plc: ICON is one of the largest global clinical research organizations (CROs) and post-PRA Health Sciences combination provides clinical trial services and analytics to pharma. It is a broad incumbent competing with Norstella's clinical trial intelligence (Citeline) and broader drug development offerings.
- Parexel International: Parexel is a global CRO with biopharmaceutical services spanning clinical research, real-world evidence, and commercialization. It overlaps with Norstella's clinical solutions (Citeline) and broader drug development intelligence offerings as a large established player.
Emerging players
- Definitive Healthcare: Definitive Healthcare provides commercial intelligence on healthcare providers, hospitals, and life sciences companies. It is an emerging player with partial overlap to Norstella's MMIT market access data and Skipta HCP engagement offerings, particularly for U.S. healthcare commercial intelligence.
- Aetion: Aetion is a healthcare analytics company focused on real-world evidence generation for regulatory and payer decision-making. It directly competes with portions of NorstellaLinQ and MMIT's real-world evidence capabilities, particularly for regulatory-grade RWE submissions.
- Tempus AI: Tempus AI is a healthcare AI and precision medicine company leveraging real-world data, genomic sequencing, and AI for clinical and research applications. It is an emerging player that intersects with Norstella's real-world data and AI offerings, particularly in oncology and rare disease markets.
- Flatiron Health: Flatiron Health (a Roche subsidiary) provides oncology-specific real-world data, electronic medical record solutions, and clinical research tools. It overlaps with Norstella's oncology-focused real-world data and clinical intelligence offerings as a specialized competitor.
Others
- Cognizant Life Sciences: Cognizant's life sciences division provides IT services, digital transformation, and consulting to pharma and biotech. It is adjacent to Norstella as a technology and consulting services provider serving overlapping pharma customers, but does not directly compete in pharma intelligence or clinical trial data products.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Norstella social profiles
Digital presenceNorstella financial estimates
Financial estimateRevenue estimate
Valuation estimate
Norstella leadership team
Management profileNumber of profiles
Profiles12 records
Norstella subsidiaries and ownership
Company hierarchySubsidiaries6 records
Norstella funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Norstella M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Norstella
What does Norstella do?
Norstella is a multi-brand pharmaceutical intelligence platform that provides AI-powered data, analytics, and clinical/commercial intelligence solutions across the entire drug development lifecycle — from pipeline to patient. Through its brands (Citeline, Evaluate, MMIT, Panalgo, Skipta, The Dedham Group), it offers subscription-based SaaS platforms integrating real-world data (74+ billion data points), clinical trial intelligence, market access data, forecasting, and patient journey analytics to pharmaceutical, biotech, and life sciences clients.
Is Norstella a public or private company?
Norstella is a private company. It is classified as unknown and is currently operating.
When was Norstella founded?
Norstella was founded in 2022. It employs 1,001 to 5,000 people.
Where is Norstella based?
Norstella is headquartered in Yardley, United States, in the North America region.
How does Norstella make money?
One revenue line is on record: pharma Intelligence SaaS Platforms.
Who are Norstella's main competitors?
Direct peers on record are IQVIA, Clarivate and Veeva Systems. Broad incumbents are ICON plc and Parexel International. Emerging players are Definitive Healthcare, Aetion, Tempus AI and Flatiron Health. Cognizant Life Sciences is listed as an others.
Does Norstella have an API?
No public API is recorded for Norstella.
What industry is Norstella in?
Norstella's product category is Pharmaceutical Intelligence / Life Sciences Analytics. Its primary akta.pro industry code is HLAIALAH, Regulatory Strategy & IND/NDA/BLA Submissions Support, with a secondary code of HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools. Its NAICS code is 5132.